Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center.
Saved in:
| Title: | Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center. |
|---|---|
| Authors: | Gibb A; The Christie NHS Foundation Trust, Manchester, UK., Jones C, Bloor A, Kulkarni S, Illidge T, Linton K, Radford J |
| Source: | Haematologica [Haematologica] 2013 Apr; Vol. 98 (4), pp. 611-4. Date of Electronic Publication: 2012 Oct 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23065511 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gibb+A%22">Gibb A</searchLink>; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Jones+C%22">Jones C</searchLink><br /><searchLink fieldCode="AU" term="%22Bloor+A%22">Bloor A</searchLink><br /><searchLink fieldCode="AU" term="%22Kulkarni+S%22">Kulkarni S</searchLink><br /><searchLink fieldCode="AU" term="%22Illidge+T%22">Illidge T</searchLink><br /><searchLink fieldCode="AU" term="%22Linton+K%22">Linton K</searchLink><br /><searchLink fieldCode="AU" term="%22Radford+J%22">Radford J</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2013 Apr; Vol. 98 (4), pp. 611-4. <i>Date of Electronic Publication: </i>2012 Oct 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23065511 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3324/haematol.2012.069393 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 611 Titles: – TitleFull: Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gibb A – PersonEntity: Name: NameFull: Jones C – PersonEntity: Name: NameFull: Bloor A – PersonEntity: Name: NameFull: Kulkarni S – PersonEntity: Name: NameFull: Illidge T – PersonEntity: Name: NameFull: Linton K – PersonEntity: Name: NameFull: Radford J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2013 Apr Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1592-8721 Numbering: – Type: volume Value: 98 – Type: issue Value: 4 Titles: – TitleFull: Haematologica Type: main |
| ResultId | 1 |
